Table 3.
Adverse effects attributable to the study drug.
| Parameters | Control (n = 29) | Case (n = 57) |
|---|---|---|
| Nausea | 2 | 0 |
| Vomiting | 1 | 0 |
| Dyspepsia | 0 | 0 |
| Diarrhoea | 1 | 1 |
| Constipation | 9 | 5 |
| Rash | 2 | 0 |
| Hypersensitivity | 1 | 0 |
Adverse effects attributable to the study drug.
| Parameters | Control (n = 29) | Case (n = 57) |
|---|---|---|
| Nausea | 2 | 0 |
| Vomiting | 1 | 0 |
| Dyspepsia | 0 | 0 |
| Diarrhoea | 1 | 1 |
| Constipation | 9 | 5 |
| Rash | 2 | 0 |
| Hypersensitivity | 1 | 0 |